BREITMEYER JAMES B 4
4 · Oncternal Therapeutics, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
BREITMEYER JAMES B
DirectorPresident, CEO
Transactions
- Award
Stock Option
2024-02-14+28,400→ 28,400 totalExercise: $9.18Exp: 2034-02-14→ Common Stock (28,400 underlying) - Award
Stock Option
2024-02-14+6,200→ 6,200 total(indirect: By Spouse)Exercise: $9.18Exp: 2034-02-14→ Common Stock (6,200 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest on first anniversary of the date of grant, and the remaining shares subject to the option vest in 36 equal monthly installments, subject to the recipient's continued employment or service with the Issuer on each such date.